Case Study: Halozyme's XYOSTED boosts digital engagement with TMC Strategic Communications

Halozyme launches a new XYOSTED website with TMC in 20+ years of healthcare experience

Halozyme, a US-based biopharmaceutical company, needed to ensure its groundbreaking XYOSTED testosterone replacement therapy stood out in a crowded market. The challenge was to redesign its digital platform with a contemporary look to increase patient conversion, all while adhering to strict pharmaceutical regulations. They partnered with TMC Strategic Communications for its expertise in UX/UI design and web development.

TMC Strategic Communications implemented a mobile-first website redesign, beginning with a competitor immersion and technical audit. They rebuilt the sitemap, developed a component library for flexibility, and navigated the stringent MLR review process to ensure compliance. The new digital platform, which unified the refreshed branding, successfully launched and has already had a significant influence on the brand's digital marketing success.

Halozyme